EXECUTIVE SUMMARY - GOLD

pulmonary disease. Respir Care Clin N Am
1998;4(3):425-38.
263. Peach H, Pathy MS. Follow-up study of
disability among elderly patients discharged
from hospital with exacerbations of chronic
bronchitis. Thorax 1981;36(8):585-9.
264. Eaton T, Withy S, Garrett JE, Mercer J,
Whitlock RM, Rea HH. Spirometry in
primary care practice: the importance of
quality assurance and the impact of
spirometry workshops. Chest
1999;116(2):416-23.
265. Schermer TR, Jacobs JE, Chavannes NH,
Hartman J, Folgering HT, Bottema BJ, et al.
Validity of spirometric testing in a general
practice population of patients with chronic
obstructive pulmonary disease (COPD).
Thorax 2003;58(10):861-6.
266. Schermer T, Eaton T, Pauwels R, van
Weel C. Spirometry in primary care: is it good
enough to face demands like World COPD
Day Eur Respir J 2003;22(5):725-7.
267. Rea H, McAuley S, Stewart A, Lamont C,
Roseman P, Didsbury P. A chronic disease
management programme can reduce days in
hospital for patients with chronic obstructive
pulmonary disease. Intern Med J
2004;34(11):608-14.
268. Kessler R, Stahl E, Vogelmeier C,
Haughney J, Trudeau E, Lofdahl CG,
Partridge MR. Patient understanding,
detection, and experience of COPD
exacerbations: an observational, interviewbased
study. Chest 2006 Jul;130(1):133-42.
269. Tonnesen P, Mikkelsen K, Bremann L.
Nurse-conducted smoking cessation in
patients with COPD using nicotine sublingual
tablets and behavioral support. Chest 2006
Aug;130(2):334-42.
270. Zhou Y, Wang X, Zeng X, Qiu R, Xie J,
Liu S, Zheng J, Zhong N, Ran P. Positive
benefits of theophylline in a randomised,
double-blind, parallel-group,
placebocontrolled study of low-dose, slowrelease
theophylline in the treatment of COPD
for 1 year. Respirology 2006 Sep;11(5):603-
10.
271. Calverley PM, Anderson JA, Celli B,
Ferguson GT, Jenkins C, Jones PW, Yates JC,
Vestbo J; TORCH investigators. Salmeterol
and fluticasone propionate and survival in
chronic obstructive pulmonary disease. N
Engl J Med. 2007 Feb 22;356(8):775-89.
272. Kardos P, Wencker M, Glaab T,
Vogelmeier C. Impact of
salmeterol/fluticasone propionate versus
salmeterol on exacerbations in severe chronic
obstructive pulmonary disease. Am J Respir
Crit Care Med 2007 Jan 15;175(2):144-9.
273. Rennard SI, Fogarty C, Kelsen S, Long
W, Ramsdell J, Allison J, Mahler D, Saadeh
C, Siler T, Snell P, Korenblat P, Smith W,
Kaye M, Mandel M, Andrews C, Prabhu R,
Donohue JF, Watt R, Lo KH, Schlenker-
Herceg R, Barnathan ES, Murray J; COPD
Investigators. The safety and efficacy of
infliximab in moderate to severe chronic
obstructive pulmonary disease. Am J Respir
Crit Care Med 2007 May 1;175(9):926-34.
274. Guo R, Pittler MH, Ernst E. Herbal
medicines for the treatment of COPD: a
systematic review. Eur Respir J 2006
Aug;28(2):330-8.